New products
Labcorp announces colorectal cancer test availability in US
Labcorp announced US availability of ColoSense, an FDA-approved RNA-based at-home screening test for colorectal cancer. The test expands Labcorp's diagnostic offering in the colorectal cancer screening market, bringing an alternative to existing screening modalities.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network